Aims: β-adrenergic receptor (β-AR) stimulation increases extracellular levels of ubiquitin (UB), and exogenous UB plays an important role in β-AR-stimulated myocardial remodeling with effects on heart function, fibrosis and myocyte apoptosis. Cardiac fibroblasts are vital for maintaining the normal function of the heart, and in the structural remodeling of the heart in response to injury. Here we hypothesized that extracellular UB modulates cardiac fibroblast phenotype and function via its interaction with CXC chemokine receptor type 4 (CXCR4). Main methods: Serum starved adult cardiac fibroblasts were used to identify CXCR4 as a receptor for UB. Fluorescent microscopy, co-immunoprecipitation, western blot, proliferation, migration and collagen contraction assays were performed to investigate the role of UB/CXCR4 axis on cell signaling, and modulation of fibroblast phenotype and function. Key findings: Using fluorescent microscopy and co-immunoprecipitation assay, we provide evidence that extracellular UB interacts with CXCR4. CXCR4 antagonist, AMD3100, inhibited interaction of UB with CXCR4. UB activated ERK1/2, not Akt. It enhanced VEGF-A expression, while decreasing β3 integrins expression. Two mutated UB proteins (V70A and F4A; unable to interact with CXCR4) failed to affect the expression of VEGF-A and β3 integrins. UB treatment inhibited migration of cells into the wound and FBS-stimulated cell proliferation. UB enhanced expression of α-smooth muscle actin (marker of myofibroblast differentiation) and contraction of fibroblast-populated collagen gel pads. Most of the effects of UB were negated by AMD3100. Significance: The data presented here suggest that UB interacts with CXCR4, and UB/CXCR4 interaction affects intracellular signaling, and modulates fibroblast phenotype and function.
Introduction
Ubiquitin (UB), a highly conserved protein of~8.5 kDa, is found in all eukaryotic cells. The most important intracellular function of UB is to regulate protein turnover via the ubiquitin-proteasome pathway [1] . The ubiquitin-proteasome pathway is suggested to regulate receptor internalization, hypertrophic response, apoptosis, and tolerance to ischemia and reperfusion in cardiac myocytes [2] . UB is a normal constituent of plasma. Elevated levels of UB are described in the serum or plasma of patients with parasitic and allergic diseases [3] , alcoholic liver disease [4] , type 2 diabetes [5] , β2-microglobulin amyloidosis [6] and chronic hemodialysis [7] . Patients with traumatic brain injury are shown to have increased UB levels in the cerebrospinal fluid [8] .
Extracellular UB is proposed to have pleiotropic functions including regulation of immune response, anti-inflammatory and neuroprotective activities [9] [10] [11] [12] , as well as regulation of growth and apoptosis in hematopoietic cells [13] . Previously our lab has shown that β-adrenergic receptor (β-AR) stimulation increases extracellular levels of UB, and treatment of adult rat ventricular myocytes with UB inhibits β-AR-stimulated apoptosis [14] . In vivo, exogenous UB decreased β-AR-stimulated increases in cardiac myocyte apoptosis and myocardial fibrosis [15] .
The G protein-coupled receptor CXC chemokine receptor type 4 (CXCR4) is expressed by a variety of cell types, including cardiac fibroblasts and myocytes [16] . CXCR4 plays an important role in a variety of biological processes, and is suggested to be involved in the https://doi.org/10.1016/j.lfs.2018.09.012 Received 6 July 2018; Received in revised form 29 August 2018; Accepted 4 September 2018 pathophysiology of various disease processes, such as cancer, HIV, ischemic myocardial injury, and angiogenesis [17] . Stromal derived factor-1α (SDF-1α) is a cognate ligand for CXCR4 [18] . SDF-1α/CXCR4 axis is shown to have cardioprotective effects against ischemia/reperfusion injury by promoting anti-apoptotic program [18] . Interestingly, CXCR4 is identified as a receptor for UB in THP1 leukemia cell line [19] . UB-CXCR4 interaction follows a two-site binding mechanism in which the hydrophobic surfaces surrounding Phe-4 and Val-70 are important for receptor binding, whereas the flexible C terminus facilitates receptor activation [20] . We have provided evidence that UB, acting via CXCR4 receptor, increases expression of angiogenic molecules and stimulates angiogenesis in cardiac microvascular endothelial cells [21] .
Fibroblasts play a critical role in maintaining the normal function of the heart, and in the remodeling process of the heart that occurs in response to myocardial infarction, hypertension and heart failure [22] . The objective of this study was to investigate the role of UB/CXCR4 axis in the modulation of fibroblast phenotype and function. The data presented here suggest that extracellular UB interacts with CXCR4, and affects fibroblast phenotype and function, at least in part, via the involvement of CXCR4.
Materials and methods

Vertebrate animals
All experiments and procedures were reviewed and approved by the East Tennessee State University Committee on Animal Care. The investigation conforms to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996). Male Sprague-Dawley rats (average weight: 200-225 g; Harlan, Indianapolis, IN) were used for isolation of resident cardiac fibroblast cells. Rats were anesthetized using a mixture of isoflurane (2.5%) and oxygen (0.5 l/min), and the heart was excised following a bilateral cut in the diaphragm. Fig. 1 . Extracellular UB interacts with CXCR4: A. Cardiac fibroblasts were incubated with FITC-UB (500 ng/ml) or FITC-labeled secondary antibodies (CTL-FITC) for 30 min. The cells were visualized by fluorescent microscope and photographed. CTL, control. B. Cells were pretreated with AMD3100 (AMD; 10 μM) for 30 min followed by treatment with b-UB for 15 min, 3 h or 24 h. Cell lysates were analyzed by western blot using extra-avidin peroxidase. C. Fibroblasts were treated with biotin-labeled UB (b-UB; 10 μg/ml) for 30 min. Cell lysates were immunoprecipitated with anti-CXCR4 antibodies.
h
Immunoprecipitates were analyzed by western blot using extra-avidin peroxidase to detect bUB and anti-CXCR4 antibodies to detect CXCR4.
Fibroblast isolation and treatment
Adult rat cardiac fibroblasts were isolated as described [15, 23] . The cells were grown to confluence and serum-starved for 48 h before use. Experiments were performed using first and second passage cells. The cells were pretreated with AMD3100 (AMD; 10 μM; Sigma) or PD98059 (PD; 15 μM; Calbiochem) for 30 min followed by treatment with UB (10 μg/ml; Sigma), biotin-UB (bUB; 500 ng/ml; Boston Biochem), or mutated UB proteins (V70A and F4A; 10 μg/ml; Boston Biochem) for indicated time points. In mutated UB proteins, Val-70 (V70A) and Phe-4 (F4A) are mutated to Ala. To investigate cellular interaction of UB, cells were treated with FITC-UB (500 ng/ml; Boston Biochem) or FITC-labeled secondary antibodies (negative control) for 30 min. The concentration of UB (10 μg/ml; Sigma) is selected based on our previously published report in adult rat cardiac myocytes [14] , where we observed that lower concentrations (0.01, 0.1, and 1 μg/ml) partially inhibit β-AR-stimulated myocyte apoptosis. However, a concentration of 10 μg/ ml almost completely inhibits β-AR-stimulated apoptosis. Normal human serum is described to have UB concentrations ranging from 30 ng/ml to 120 ng/ml. Pathological conditions increase serum UB concentrations. Burn injury in humans associates with increased serum UB levels of~800 ng/ml [12] .
Co-immunoprecipitation assay
Serum-starved cells were treated with bUB for 30 min. Total cell lysates (300 μg proteins) prepared in TNT buffer (20 mM Tris·HCl, pH 7.5, 137 mM NaCl, 20 mM NaF, 5 mM EDTA, 1 mM PMSF, 10 mM sodium pyrophosphate, 0.2 M sodium orthovanadate, 8 μg/ml aprotinin and 2 μg/ml leupeptin, digitonin 0.05%, and 1% Triton X-100) were incubated overnight at 4°C with 3 μg of anti-CXCR4 antibody (Abcam). Protein A/G beads (60 μl, Thermo Scientific, Rockford, IL) were then added to the mixture and incubated for an additional hour. The beads were washed six times with TNT buffer and resuspended in sample buffer. The immunoprecipitated proteins were resolved by SDS-PAGE and transferred to PVDF membranes. The membranes were then incubated overnight in extra-avidin peroxidase (Sigma; 1:2000 dilution in TBST) and chemiluminescence reagents to detect bUB. The membranes were also probed with anti-CXCR4 antibodies.
Western blot analysis
Cell lysates (20 μg), prepared using lysis buffer [10 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1 mM EGTA, 1 mM EDTA, 0.2 mM sodium orthovanadate, 0.5% Nonidet P-40, 1% Triton X-100, and 1 mM PMSF], 2 . UB treatment activates ERK1/2, not Akt: Serum starved confluent cultures of fibroblasts were pretreated with AMD3100 (AMD), or PD98059 (PD) for 30 min followed by treatment with UB for 15 min. Cell lysates were analyzed by western blot using phospho-specific ERK1/2 (A) or Akt (serine-473; B) antibodies. The lower panels exhibit mean data normalized to total ERK1/2 or Akt; *P < 0.05 versus CTL, $ P < 0.05 versus UB, n = 4-6.
were resolved by 10% SDS-PAGE. The proteins were transferred onto PVDF membrane. The membranes were probed with primary antibodies directed against p-Akt (1:1000; Cell Signaling Tech.), p-ERK1/2 (1:2000; Cell Signaling Tech.), β3-integrin (1:1000; Santa Cruz), VEGF-A (1:200; Santa Cruz), or α-SMA (1:20,000; Sigma). The membranes were then stripped and probed with Akt, ERK1/2, actin (Chemicon) or GAPDH (Santa Cruz) antibodies to normalize protein loading. Band intensities were quantified using Kodak photo documentation system (Eastman Kodak Co.).
Proliferation assay
An equal number of fibroblasts (3 × 10 4 ) were plated on p60 culture dishes containing glass coverslips and incubated in DMEM supplemented with 10% fetal bovine serum (FBS) for 24 h at 37°C. The cells were then serum starved for 24 h (0 h control) followed by treatment with UB (10 μg/ml) in the presence or absence of FBS (1%) for 24 h. The cells were fixed using methanol (-20°C) for 10 min followed by washing with PBS. The cells were then incubated in blocking solution (5% BSA in PBS) for 1 h followed by incubation with anti-Ki-67 antibodies (Abcam) at 1:100 dilution overnight at 4°C. After washing, the cells were incubated with FITC-labeled secondary antibodies for 1 h at room temperature in the dark. The cells were then washed and stained with Hoechst 33342 (10 μM; nuclear stain). After washing and mounting, the cells were visualized using a fluorescent microscope (EVOS). Images were acquired using Life Technologies EVOS FL Auto microscope. A cell was determined to be actively proliferating if FITCKi-67 positive staining co-localized with Hoechst 33342 staining. The percentage of Ki-67-positive cells relative to the total number of nuclei (Hoechst positive) was determined by counting five randomly chosen fields per coverslip. The percentages of proliferating cells were normalized to 0 h control and are expressed as fold-change vs the 0 h control.
Migration assay
Movement of cells through a wound introduced in a cell monolayer was measured as described [21] . Briefly, fibroblasts were grown as a confluent monolayer. After serum starvation for 48 h, a wound was created in the center of the cell monolayer by gentle removal of attached cells using a sterile plastic pipette tip. Cell debris was removed by a PBS wash and images of the wound were acquired using a Nikon TE-2000 microscope equipped with a Retiga-1300 color cooled camera (0 h). The cells were then incubated in serum-free DMEM containing UB with or without AMD for 24 and 48 h. Images were again acquired 24 and 48 h after treatment. The wound area was measured using Bioquant Image Analysis software (Bioquant Image Analysis Corp., Nashville, TN). The ability of cells to migrate into the wound area was assessed by comparing micrographs at time 0, 24 and 48 h along the wounded area. The percentage of recovered wound area was calculated by dividing the wound area after 24 h or 48 h by the initial wound area at time 0 multiplied by 100.
Collagen gel pad contraction assay
Collagen gel pad contraction assay was performed as described [24] . Briefly, serum starved fibroblasts were mixed with collagen solution (1 mg/ml) to achieve the final cell count of 3 × 10 5 cells/ml. 500 μl of this suspension was aliquoted into a 24 well culture plate and allowed to polymerize at 37°C for 30 min. The gels were released from wells, transferred to p60 culture dishes, floated in DMEM and incubated at 37°C for 24 h. Fibroblast containing gels were treated with UB (10 μg/ml) or AMD (10 μM) for 24 h. For AMD + UB, AMD was added 30 min prior to UB treatment. TGF-β1 (10 nM) treatment was used as a positive control. Images were acquired at 0 h and 24 h to assess the degree of gel contraction. The area of each collagen gel pad was measured using NIS elements software (Nikon).
Statistical analysis
Data are expressed as the mean ± SEM. Data was analyzed using Student's t-test or a one-way analysis of variance (ANOVA) followed by the Student-Newman-Keuls test. Probability (P) values of < 0.05 were considered to be significant.
Results
UB interacts with CXCR4
To investigate if extracellular UB interacts with fibroblast, nonpermeabilized cells were treated with FITC-UB for 30 min. As a negative control, cells were incubated with FITC-labeled secondary antibodies (1:500) for 30 min. Visualization of cells using fluorescent microscope showed clear staining of cells with FITC-UB. No staining was observed in control cells or cells incubated with FITC-labeled secondary antibodies (Fig. 1A) . . UB treatment affects protein levels of VEGF-A and β3 integrin: Serum starved confluent cultures of fibroblasts were pretreated with AMD for 30 min followed by treatment with UB (10 μg/ml) for 24 h. The cells were also treated with mutated UBs proteins (V70A and F4A) for 24 h. Cell lysates were analyzed by western blot using anti-VEGF-A (A) or anti-β3-integrin (B) antibodies. The lower panels exhibit the mean data normalized to actin. *P < 0.05 versus CTL; $ P < 0.05 versus UB; n = 6-7.
CXCR4 is identified as a receptor for UB in THP-1 cells [19] . To show interaction of UB with CXCR4, cells were pretreated with AMD for 30 min followed by incubation with bUB for 15 min, 3 h and 24 h. Western blot analysis of cell lysates using extra-avidin peroxidase showed clear presence of bUB in the cell lysates at all time-points. Pretreatment with AMD interfered with the presence of bUB at all different time-points (Fig. 1B) . Co-immunoprecipitation is considered as a standard method to determine if two proteins of interest form a complex. To confirm interaction of UB with CXCR4 receptor, fibroblasts were treated with bUB for 30 min. Cell lysates were immunoprecipitated with anti-CXCR4 antibody. The resultant immunoprecipitates were analyzed by western blots using extra-avidin peroxidase to detect bUB. This analysis showed the presence of bUB in both samples immunoprecipitated with anti-CXCR4 antibodies (Fig. 1C). 3.2. UB/CXCR4 interaction affects activation of ERK1/2, and expression of β3 integrin and VEGF-A A variety of growth factors activate ERK1/2 [25] . UB treatment is also shown to activate ERK1/2 in THP-1 cells [26] . To analyze the activation ERK1/2 in cardiac fibroblasts and the involvement of CXCR4 receptors in UB signaling, cells were pretreated with AMD or PD (a selective inhibitor of ERK1/2 pathway) for 30 min followed by treatment with UB for 15 min. Western blot analysis of cell lysates using phospho-specific anti-ERK1/2 antibodies showed increased phosphorylation (activation) of ERK1/2 in response to UB. PD completely inhibited UB-mediated ERK1/2 activation, while AMD partially inhibited UB-stimulated increase in ERK1/2 activation (CTL, 1 ± 0.01; UB, 4.73 ± 0.8*; AMD + UB, 2.4 ± 0.8* $ ; PD + UB $ , 0.05 ± 0.02; AMD, 0.93 ± 0.38; *P < 0.05 vs CTL; $ P < 0.05 vs UB; n = 5; Fig. 2A ).
Previously, we have provided evidence that inhibition of PI3-kinase inhibits the protective effects of UB in β-AR-stimulated apoptosis in adult rat ventricular myocytes [14] . PI3-kinase acts upstream in the activation of Akt, and activation of Akt is generally considered as an anti-apoptotic signal [27] . Western blot analysis of cell lysates using phospho-specific anti-Akt antibodies showed no significant change in Akt phosphorylation in response to UB in the presence or absence of AMD (Fig. 2B) .
VEGF-A is suggested to play a role in tissue repair [28] . Extracellular UB increases VEGF-A expression in microvascular endothelial cells [21] . Western blot analysis of cell lysates using anti-VEGF-A antibodies showed a significant increase in the expression of VEGF-A in UB-treated (24 h) samples compared to CTL (Fig. 3A) . AMD alone had no effect on VEGF-A expression. However, it almost completely inhibited UB-mediated increase in VEGF-A expression (CTL, 1.00 ± 0.01; UB, 3.22 ± 0.6; AMD + UB, 1.49 ± 0.3, AMD, 1.15 ± 0.1; *P < 0.05 vs CTL; n = 5; Fig. 3A) . The UB/CXCR4 interaction is suggested to involve the hydrophobic surfaces surrounding UB residues Phe-4 and Val-70 [20] . To investigate the role these amino acid residues in UB signaling, cells were treated with two different mutated UBs proteins; V70A and F4A. Western blot analyses of cell lysates showed no effect of mutated UBs on VEGF-A protein levels.
Integrins, transmembrane receptors, are crucial for providing linkages between extracellular matrix (ECM) proteins and the actin cytoskeleton, thereby providing adhesion of cells to the substratum and playing a crucial role in cell migration [29, 30] . Cardiac fibroblasts predominantly express β3 integrins [31] . Western blot analysis of cell lysates using anti-β3-integrin antibodies showed that UB treatment significantly decreases β3 integrin protein levels (Fig. 3B) . AMD alone had no effect, however, pretreatment with AMD almost completely reversed UB-mediated decrease in β3 integrin protein levels (CTL, 1.00 ± 0.01; UB, 0.45 ± 0.09*; AMD + UB, 0.99 ± 0.22; AMD, 0.97 ± 0.18; *P < 0.05 vs CTL; n = 5; Fig. 3B ). Treatment with mutated UB (V70A and F4A) had no effect of β3 integrin protein levels (Fig. 3B). 
UB treatment affects cell migration and proliferation
Fibroblast migration is an essential early event in wound healing and deposition of fibrosis [32] . To examine the effect of UB on cell migration, we used an in vitro migration (scratch) assay. Migratory potential of fibroblasts into the wound was clearly present in the untreated cells as observed by the decrease in the percent wound area recovered 24 and 48 h after incubation. Interestingly, UB treatment significantly inhibited the percent wound area recovered at both time points (Fig. 4) . AMD pretreatment negated the effects of UB on cell migration at both time points (% wound area recovered; 24 h; CTL, 45 ± 3; UB, 14 ± 4*; AMD + UB, 34 ± 6 $ ; AMD, 47 ± 3; 48 h; CTL, 64 ± 2; UB, 35 ± 6*; AMD + UB, 59 ± 5 $ ; AMD, 63 ± 5; *P < 0.05 vs CTL; $ P < 0.05 vs UB; n = 5; Fig. 4B & C) . AMD alone had no effect on the migration of cells into the wound.
Ki-67 is found in the nucleus of proliferating cells and is commonly used as an index of proliferation [33] . It is undetectable during G0 phase, but peaks during the G2/mitosis phase [34] . Treatment of cells with UB alone for 24 h had no effect on the percentage of Ki 
UB treatment increases α-SMA expression and contraction of fibroblast-populated collagen gel pads
Expression of α-SMA serves as a marker of myofibroblasts [35] . To investigate if extracellular UB affects α-SMA expression, serum-starved fibroblasts were treated with UB for 48 h. Western blot analysis of cell lysates showed a significant increase in α-SMA expression in UB-treated cells vs CTL (Fig. 6A) . Collagen gel contraction assay is frequently used to evaluate the ability of fibroblasts to reorganize and contract the collagen matrix in vitro [36] . To investigate the role of UB in this process, collagen gel contraction assay was performed using a protocol received from Dr. Frangogiannis (Albert Einstein College of Medicine, Bronx, NY) [24] . This analysis showed that UB significantly increases the contraction of fibroblast-populated collagen pads, an observation similar to that of TGF-β1 (used as positive control). AMD alone had no effect on collagen gel contraction. However, it significantly reduced UBmediated increase in collagen gel pad contraction (Fig. 6B ).
Discussion
Cardiac fibroblasts play a critical role in maintaining normal function of the heart, and in cardiac remodeling during pathological conditions [22] . A major finding of this study is that UB modulates intracellular signaling, phenotype and function of fibroblasts via the involvement of CXCR4. The data presented here demonstrate that UB interacts with CXCR4. UB/CXCR4 interaction activates intracellular signaling, and affects expression of β3 integrins and VEGF-A. It inhibits the migration of cells into the wound and FBS-stimulated cell proliferation, while enhancing α-SMA expression and contraction of CXCR4 (a cognate receptor for stromal derived factor-1α; SDF-1α) is identified as a receptor for extracellular UB in THP1 leukemia cells [19] . Although both UB and SDF-1α can signal via CXCR4, important differences have been identified in their receptor binding and signaling. For example, SDF-1α, not UB, binds to CXCR7 [26] . Binding affinity of SDF-1α with CXCR7 is 10-fold higher than with CXCR4 [37] . Interaction of UB with CXCR4 occurs independent of the N-terminus of CXCR4 and does not follow the typical two-site binding mechanism of chemokine-receptor [26] . UB/CXCR4 interaction differentially affects receptor desensitization [38] and exhibits weaker chemotactic activity (vs SDF-1α/CXCR4) in cell migration assay and does not reduce HIV-1 infectivity [17, 19] . CXCR4 amino acid residues (Phe-29, Phe-189, Lys-271) play an important role in UB/CXCR4 interaction. However, these residues do not contribute to the binding of SDF-1α with CXCR4 [20] . Thus, UB contains separate receptor docking and activation sites, and signals through CXCR4 via a unique binding mechanism. Myocytes and non-myocyte cell populations of the heart express CXCR4 [39] . Previously, we provided evidence for CXCR4 as a receptor for extracellular UB in microvascular endothelial cells [21] . Here, we provide evidence for CXCR4 as a potential receptor for UB in cardiac fibroblasts. CXCR4 antagonist, AMD3100, decreased levels of bUB in the cell lysates. bUB also co-immunoprecipitated with CXCR4. Other signaling, phenotypic and functional parameters were also negated by AMD treatment. Use of mutated UB proteins (F4A and V70A) further supports the involvement of CXCR4 in UB signaling. It is interesting to note that CXCR4 antagonist, AMD3100, almost completely inhibits UB-mediated changes in the expression of VEGF-A and β3 integrin. However, inhibition of ERK1/2 was partial. In THP-1 cells, UB is shown to induce intracellular signaling, including phosphorylation of ERK1/2 and Akt [26] . In adult rat ventricular myocytes, UB alone had no effect on the activation of JNKs and glycogen synthase kinase-3β (GSK-3β) [14] . The reasons for this differential response may reflect cell-type specific differences and/ or differences in binding affinities of AMD and UB. Furthermore, CXCR4 can act as a homodimer or heterodimer with CXCR7 [40] , β2-adrenergic receptor (β2-AR) [41] or α1A-AR [42, 43] . Future investigations are needed to clarify the role of these other receptors in UB signaling.
Fibroblasts are capable of modulating their microenvironment through autocrine and paracrine signaling, thereby playing a role in tissue remodeling following tissue injury. Fibroblasts are also shown to play a role in the angiogenic process [44, 45] . Fibroblasts secrete growth factors, including VEGF-A [46] . VEGF-A is considered as a potent angiogenic inducer. In this study, we found that UB treatment increases VEGF-A expression. Increased expression of VEGF-A is consistent with our previous finding in microvascular endothelial cells where UB treatment increased VEGF-A expression [21] . Increased expression of VEGF-A may act as a paracrine factor for cardiac microvascular endothelial cells to induce angiogenesis.
Integrins are cell surface receptors that play a role in cell adhesion and migration, as well as in growth and survival [30, 47] . Cardiac fibroblasts express β3 integrin [48] . β3 integrin is shown to play a critical role in cardiac fibroblasts adhesion, migration, proliferation and extracellular matrix production since β3 integrin null cardiac fibroblast exhibit a significant reduction in these processes [31] . Here, UB treatment decreased β3 integrin protein levels and inhibited fibroblast migration into the wound area. Therefore, it is possible that the UBmediated decrease in β3 integrin may play a role in decreased cell migration in response to UB.
Activated fibroblasts play a critical role in both the reparative and fibrotic processes. Compromising the ECM composition after large injuries such as myocardial infarction (MI) destabilizes the heart and predisposes it to cardiac rupture [49, 50] . Since fibroblasts play an integral role in composition of the ECM and collagen-based scar formation, it is likely that inhibition of fibroblast proliferation would predispose the heart to cardiac rupture post-MI. Conversely, rapid proliferation of fibroblasts and subsequent deposition of extracellular matrix post-MI also associates with adverse effects on cardiac structure and function [51] . Therefore, a well-controlled balance between fibroblast proliferation and ECM deposition is integral in the maintenance of ECM homeostasis. Here, we observed that UB significantly inhibits FBS-mediated increase in proliferation of cardiac fibroblasts. UB alone had no effect on fibroblast proliferation. In KT-3 and HL-60 cells, UB is shown to inhibit cell growth via selective degradation of the STAT3 transcription factor [13] . Previously, our lab has provided evidence that UB inhibits β-AR stimulated increase in cardiac fibrosis [15] . It also enhanced expression of matrix metalloproteinases (MMP-2 and MMP-9) in the heart and cardiac fibroblasts [15] . Together, these data suggest that UB has the potential to decrease myocardial fibrosis by modulating expression of MMPs and/or fibroblast proliferation.
In normal tissues, resident fibroblasts are quiescent, producing limited amounts of ECM proteins and exhibiting few actin-associated cell-matrix and cell-cell contacts [52] . Tissue injury induces alterations in the microenvironment, resulting in differentiation of fibroblasts into myofibroblasts. Myofibroblasts are characterized by the presence of microfilamentous contractile apparatus enriched in α-SMA fibers [53] . Myofibroblasts have the ability to contract to close wounds effectively because of their α-SMA reinforced actin structure [54] . Once the myofibroblasts adhere to multiple points in the wounded or stressed area, the α-SMA reinforced fibers pull the adherence points closer together generating wound contracture. This effect is mirrored in the collagen gel contraction assays in vitro [55] . In hepatic stellate cells, stimulation of SDF-1α/CXCR4 axis is shown to promote the contraction of collagen gels, which was inhibited by pretreatment with AMD [56] . Here UB enhanced expression of α-SMA, a hallmark of differentiated fibroblasts into myofibroblasts. It also increased the contraction of fibroblast-populated collagen pads. AMD negated the effect of UB on collagen pad contraction. These data suggest a role for the UB/CXCR4 axis in modulation of fibroblast function.
Reduced cell migration and proliferation in response to UB treatment suggest an anti-fibrotic role for UB, while the apparent increase in α-SMA expression is indicative of a pro-fibrotic role. Deposition of collagen-rich ECM associates with α-SMA-positive myofibroblasts [57] . However, caution should be exercised while interpreting the results obtained using cardiac fibroblasts in vitro. Although in vitro cell culture provides a useful tool to understand cell biology, behavior of fibroblasts may vary depending on their microenvironment and culture conditions. Of note, overexpression of α-SMA is shown to attenuate serum-stimulated fibroblast proliferation [24] .
Conclusion
Cardiac fibroblasts are important in maintaining the normal function of the heart as well as in wound repair following injury to the heart. UB is found in normal plasma. A variety of disease states increase levels of UB in the plasma. Here we provide evidence that UB modulates cardiac fibroblast function and phenotype via the involvement of CXCR4. Further investigation of mechanisms leading to UB-mediated regulation of cardiac fibroblast function and phenotype may help uncover novel strategies to improve cardiac remodeling and function following pathological stress. 
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